151 related articles for article (PubMed ID: 20387134)
1. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.
Fallavollita JA; Luisi AJ; Yun E; deKemp RA; Canty JM
J Nucl Cardiol; 2010 Aug; 17(4):637-45. PubMed ID: 20387134
[TBL] [Abstract][Full Text] [Related]
2. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
3. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
[TBL] [Abstract][Full Text] [Related]
4. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
[TBL] [Abstract][Full Text] [Related]
5. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
Masi S; Lautamäki R; Guiducci L; Di Cecco P; Porciello C; Pardini S; Morales MA; Chubuchny V; Salvadori PA; Emdin M; Sironi AM; Knuuti J; Neglia D; Nuutila P; Ferrannini E; Iozzo P
Diabetologia; 2012 Sep; 55(9):2494-500. PubMed ID: 22752026
[TBL] [Abstract][Full Text] [Related]
6. Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac
Luong TV; Pedersen MGB; Kjærulff MLBG; Madsen S; Lauritsen KM; Tolbod LP; Søndergaard E; Gormsen LC
Metabolism; 2021 Oct; 123():154862. PubMed ID: 34375646
[TBL] [Abstract][Full Text] [Related]
7. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
[TBL] [Abstract][Full Text] [Related]
9. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
10. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
[TBL] [Abstract][Full Text] [Related]
11. Role of quantitative myocardial blood flow and
Benz DC; Ferro P; Safa N; Messerli M; von Felten E; Huang W; Patriki D; Giannopoulos AA; Fuchs TA; Gräni C; Gebhard C; Pazhenkottil AP; Kaufmann PA; Buechel RR
J Nucl Cardiol; 2021 Feb; 28(1):263-273. PubMed ID: 30895563
[TBL] [Abstract][Full Text] [Related]
12. Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy.
Stolen KQ; Kemppainen J; Kalliokoski KK; Luotolahti M; Viljanen T; Nuutila P; Knuuti J
J Nucl Cardiol; 2003; 10(5):447-55. PubMed ID: 14569237
[TBL] [Abstract][Full Text] [Related]
13. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of cardiac 18 F-FDG viability PET: a retrospective study of 44 patients undergoing post-test revascularization.
Luong TV; Ebbehoj A; Kjaerulff MLG; Nielsen R; Nielsen PH; Christiansen EH; Tolbod LP; Søndergaard E; Gormsen LC
Int J Cardiovasc Imaging; 2022 Nov; 38(11):2447-2458. PubMed ID: 36434332
[TBL] [Abstract][Full Text] [Related]
15. Insulin-stimulated myocardial glucose uptake and the relation to perfusion and the nitric oxide system.
Søndergaard HM; Bøttcher M; Schmitz O; Nielsen TT; Bøtker HE
J Vasc Res; 2004; 41(1):38-45. PubMed ID: 14726631
[TBL] [Abstract][Full Text] [Related]
16. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based
Hu L; Qiu C; Wang X; Xu M; Shao X; Wang Y
BMC Cardiovasc Disord; 2018 Oct; 18(1):203. PubMed ID: 30373519
[TBL] [Abstract][Full Text] [Related]
17. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats.
Ménard SL; Croteau E; Sarrhini O; Gélinas R; Brassard P; Ouellet R; Bentourkia M; van Lier JE; Des Rosiers C; Lecomte R; Carpentier AC
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1049-57. PubMed ID: 20159856
[TBL] [Abstract][Full Text] [Related]
18. Spatial heterogeneity in fasting and insulin-stimulated (18)F-2-deoxyglucose uptake in pigs with hibernating myocardium.
Fallavollita JA
Circulation; 2000 Aug; 102(8):908-14. PubMed ID: 10952961
[TBL] [Abstract][Full Text] [Related]
19. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
[TBL] [Abstract][Full Text] [Related]
20. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
Nielsen R; Jorsal A; Iversen P; Tolbod L; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Bøtker HE; Wiggers H
J Nucl Cardiol; 2018 Feb; 25(1):169-176. PubMed ID: 27473218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
